Diagnostik und Therapie des Hypoparathyreoidismus

Deutsche Medizinische Wochenschrift

Volumn 121, Issue 25-26, 1996, Pages 841-844

  Schilling, T ^a   Ziegler, R ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIFEDIOL; CALCITRIOL; COLECALCIFEROL; DIHYDROTACHYSTEROL; GLUCONATE CALCIUM;

DIAGNOSTIC ACCURACY; HUMAN; HYPOPARATHYROIDISM; INTRAVENOUS DRUG ADMINISTRATION; SHORT SURVEY;

CALCIUM; DIAGNOSIS, DIFFERENTIAL; HUMANS; HYPOCALCEMIA; HYPOPARATHYROIDISM;

EID: 1842534415     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1043076     Document Type: Article

References (17)

1. Bilous, R. W., G. Murty, D. B. Parkinson, R. V. Thakker, M. G. Coulthard, J. Burn, D. Mathias, P. Kendall-Taylor: Autosomal dominant familial hypoparathyroidism, sensorineural deafness, and renal dysplasia. New Engl. J. Med. 327 (1992), 1069-1074.
2. Chase, L. R., G. L. Melson, G. D. Aurbach: Pseudohypoparathyreoidism. Defective excretion of 3′,5′-AMP in response to parathyroid hormone. J. clin. Invest. 48 (1969), 1832-1844.
3. Di-George, A. M.: Congenital absence of the thymus and its immunologic consequences. Concurrence with congenital hypoparathyroidism. Birth Defects 4 (1968), 116-123.
4. Drezner, M. K., F. A. Neelon, H. E. Lebovitz: Pseudohypoparathyroidism type II. A possible defect in the reception of the cyclic AMP signal. New Engl. J. Med. 289 (1983), 1056-1060.
5. Glover, D. J., L. Riley, K. Carmichael, B. Spar, J. Glick, Z. Agus, E. Slatopolsky, M. Attie, S. Goldfarb: Hypocalcemia and inhibition of parathyroid hormone secretion following administration of WR 2721 (a radio- and chemoprotective agent). New Engl. J. Med. 309 (1983), 1137-1141.
6. Laitinen, K., C. Lamberg-Allardt, R. Tunninen, S.-L. Karonen, R. Tähtelä, R. Ylikahri, M. Välimäki: Transient hypoparathyreoidism during acute alcohol intoxication. New Engl. J. Med. 324 (1991), 721-727.
7. Laitinen, K., R. Tähtelä, M. Välimäki: The dose-dependency of alcohol-induced hypoparathyroidism, hypercalciuria, and hypermagnesuria. Bone and Mineral 19 (1992), 75-83.
8. Müller, W., H. H. Peter, M. Wilken, H. Jüppner, H. C. Kallfelz, H. P. Krohn, K. Miller, C. H. L. Rieger: The DiGeorge syndrome. I. Clinical evaluation and course of partial and complete forms of the syndrome. Europ. J. Pediat. 147 (1988), 496-502.
9. Nagant de Deuxchaisnes, C., S. M. Krane: Hypoparathyroidism. In Avioli, C. V., S. M. Krane (Ed.): Metabolic Bone Disease, Vol. II (Academic Press: New York 1978), 218-445.
10. Patten, J. L., D. R. Johns, D. Valle, C. Eil, P. A. Gruppuso, G. Steele, P. M. Smallwood, M. A. Levine: Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright's hereditary osteodystrophy. New Engl. J. Med. 322 (1990), 1412-1419.
11. Pellock, J. M., M. Behrens, L. Lewis, D. Holub, S. Carter, L. P. Rowland: Kearns-Sayre syndrome and hypoparathyroidism. Ann. Neurol. 3 (1978), 455-458.
12. Reber, P. M., H. Health III: Hypocalcemic emergencies. Endocr. Emerg. 79 (1995), 93-106.
13. Weinstein, L. S., P. V. Gejman, E. Friedman, T. Kadowaki, R. M. Collins, E. S. Gershon, A. M. Spiegel: Mutations of the Gs alpha-subunit gene in Albright hereditary osteodystrophy detected by denaturing gradient gel electrophoresis. Proc. nat. Acad. Sci. (Wash.) 87 (1990), 8287-8290.
14. Ziegler, R.: Die Therapie des tetanischen Syndroms. Dtsch. med. Wschr. 110 (1985), 424-427.
15. Ziegler, R.: Behandlung des Hypoparathyreoidismus - womit? Dtsch. Ärztebl. 38 (1989), 2667-2668.
16. Ziegler, R., H. Minne, F. Raue, G. Paar, G. Delling: Beobachtungen zur Vitamin-D und Dihydrotachysterin-Vergiftung. Dtsch. med. Wschr. 100 (1975), 415-423.
17. Zofkova, I., R. L. Kancheva: The relationship between magnesium and calciotropic hormones. Magnesium Res. 8 (1995), 77-84.